COVID Testing Expands to Albany International Airport

News Archives - Quadrant Biosciences

COVID Testing Expands to Albany International Airport

Since December, the Albany International Airport has been offering covid testing to all travellers and staff at the airport. The test, called the Clarifi COVID-19 Test Kit, was co-developed by Quadrant Biosciences and SUNY Upstate Medical University in Syracuse, and has been used to test over a half million students and faculty at SUNY colleges

Read More...

Saliva May Be the Key to Concussion Diagnosis

Could saliva be the key to concussion diagnosis and management?  Scientists say yes, according to the study “Diagnosing Mild Traumatic Brain Injury Using Saliva RNA Compared to Cognitive and Balance Testing,” published in Clinical and Translational Medicine. Researchers from Quadrant Biosciences, Penn State College of Medicine, SUNY Buffalo Jacobs School of Medicine, and SUNY Medical

Read More...

Quadrant Biosciences on Capitol Hill

An update from the CEO, Rich Uhlig. I hope everyone is staying safe in these tumultuous times. I wanted to update you on my recent visit to Washington D.C. to engage with key members of Congress and the Executive Branch about our autism saliva test, Clarifi ASD. My colleagues from Quadrant and I had the

Read More...

Autism Saliva Test Aims to Reduce Age of Diagnosis

Increasingly, more research is being published globally supporting the gut-brain connection theory and the important role of epigenetics and the microbiome in relation to autism spectrum disorder (ASD). In 2018, scientists discovered that certain molecules in the saliva, called non-coding RNAs, not only differentiate children with ASD, but appear to correlate with specific autism traits.

Read More...

Bacteria Within A a Child’s Mouth Could Help Identify Autism

New research has recently emerged that “changes in the bacteria within a child’s mouth may provide biomarkers for identifying autism.”[1]  This technology is being developed into a saliva test which will aid clinicians in autism diagnosis. Previous research has established the presence of a disrupted gut-brain signaling in children with autism spectrum disorder (ASD). [2]

Read More...

Quadrant Biosciences Wins New York Technology Award

Quadrant Biosciences Wins New York Technology Award We’re excited to share that our company, Quadrant Biosciences, has been recognized as the New York Technology Business of the Year for our breakthrough epigenetic research! The award, presented by the New York State Small Business Development Center (SBDC),  recognizes the boldest, brightest, and best small companies in

Read More...